DUBLIN--(BUSINESS WIRE)--The "Shoulder Replacement Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
This report provides comprehensive information about the Shoulder Replacement pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Shoulder Replacement is a surgical procedure in which certain parts of an arthritic or damaged joint are removed and replaced with prosthesis, or artificial joints.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Shoulder Replacement under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Shoulder Replacement and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Shoulder Replacement under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Products under Development
3.1 Shoulder Replacement - Pipeline Products by Stage of Development
3.2 Shoulder Replacement - Pipeline Products by Segment
3.3 Shoulder Replacement - Pipeline Products by Territory
3.4 Shoulder Replacement - Pipeline Products by Regulatory Path
3.5 Shoulder Replacement - Pipeline Products by Estimated Approval Date
3.6 Shoulder Replacement - Ongoing Clinical Trials
4 Shoulder Replacement - Pipeline Products under Development by Companies
4.1 Shoulder Replacement Companies - Pipeline Products by Stage of Development
4.2 Shoulder Replacement - Pipeline Products by Stage of Development
5 Shoulder Replacement Companies and Product Overview
5.1 BioPoly RS LLC Company Overview
5.2 CeramTec GmbH Company Overview
5.3 Cytex Therapeutics Inc Company Overview
5.4 DePuy Synthes Inc Company Overview
5.5 Exactech Inc Company Overview
5.6 FX Shoulder USA Inc Company Overview
5.7 Imperial College London Company Overview
5.8 Innovative Design Orthopaedics Ltd Company Overview
5.9 Integra LifeSciences Holdings Corp Company Overview
5.10 Lifespans Ltd Company Overview
5.11 Limacorporate SpA Company Overview
5.12 Orbis Medisch Centrum Company Overview
5.13 Shanghai EndoPhix Medical Technology Co Ltd Company Overview
5.14 Shoulder Innovations LLC Company Overview
5.15 Shoulder Options, Inc. Company Overview
5.16 Stryker Corp Company Overview
5.17 Topsfield Medical GmbH Company Overview
5.18 University of Utah Company Overview
5.19 Wright Medical Group NV Company Overview
6 Shoulder Replacement- Recent Developments
6.1 May 20, 2022: Ortho Regenerative Technologies Reports Its Fourth Quarter and 2022 Year-end Results
6.2 May 16, 2022: Zimmer Biomet Announces Appointment of New Chief Accounting Officer
6.3 May 03, 2022: Zimmer Biomet Announces First Quarter 2022 Financial Results
6.4 Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update
6.5 Mar 31, 2022: Smith & Nephew announces Directorate Change
6.6 Mar 22, 2022: Depressive disorder may hinder healing in patients undergoing reverse shoulder arthroplasty
6.7 Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer
6.8 Feb 07, 2022: Zimmer Biomet Announces Fourth Quarter and Full-Year 2021 Financial Results
6.9 Jan 21, 2022: Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of ZimVie; ZimVie to Host Investor Day on February 7
6.10 Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
6.11 Nov 18, 2021: Zimmer Biomet to Present at Evercore ISI's 4th Annual HealthCONx Conference
6.12 Nov 03, 2021: Zimmer Biomet to Present at Stifel's 2021 Virtual Healthcare Conference
6.13 Sep 30, 2021: Ortho Regenerative Technologies Reports Its Second Quarter 2022 Results
6.14 Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences
6.15 Aug 03, 2021: Zimmer Biomet Announces Second Quarter 2021 Financial Results
6.16 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results
6.17 Jul 29, 2021: Smith & Nephew announces Half-year Report
6.18 Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results
6.19 Jul 27, 2021: Stryker reports second quarter 2021 operating results
6.20 Jul 21, 2021: Ortho Regenerative Technologies Announces Voting Results of its Annual General and Special Meeting of Shareholders
6.21 Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results
6.22 Jul 07, 2021: Conformis announces settlement of Wright Medical patent litigation
6.23 Jun 15, 2021: Ortho Regenerative Technologies Appoints Two New Members to its Board of Directors
6.24 Jun 01, 2021: Ortho Regenerative Technologies Reports Its Fourth Quarter and 2021 Year-End Results
7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/hdl5bq
Source: GlobalData
